There were 148 press releases posted in the last 24 hours and 440,188 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Algernon Pharmaceuticals Announces Last Patient Out in Multinational Phase 2b/3 Human Study of Ifenprodil for COVID-19

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image